EUVIMEDEUVIMED entdecken
Crossref

Obesity and total ankle arthroplasty: Contraindication or consideration

Iosafat Pinto, Panagiotis Konstantinou, Lazaros Kostretzis, Anastasios P Nikolaides, Athina Zacharoula Ditsiou, Chrysanthos Chrysanthou, Stylianos Kapetanakis, Konstantinos Ditsios

World Journal of Orthopedics · 18.03.2026 · 17 (3)

DOI: 10.5312/wjo.v17.i3.115288 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Orthopedics, online erschienen am 18.03.2026. Verfasst von Iosafat Pinto und 7 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Obesity is increasingly common among patients undergoing total ankle arthroplasty (TAA), yet its influence on perioperative outcomes, implant survivorship, and patient-reported outcomes remains unclear. AIM To understand this relationship, which is essential for patient counseling, perioperative planning, and policy. METHODS This systematic review, registered with the Open Science Framework and conducted per Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, searched PubMed, the Cochrane Library, and CINAHL through August 2025 using: (arthroplasty OR replacement) AND ankle AND (outcome OR complication) AND obesity. Eligible studies compared obese and non-obese TAA patients. Extracted data included perioperative complications, implant revision, survivorship, and patient-reported outcome measures. Risk of bias was assessed with the Newcastle-Ottawa Scale, and due to heterogeneity, results were narratively synthesized. RESULTS Fourteen studies encompassing over 20000 patients were included. Institutional series generally found no significant association between obesity and perioperative complications, while larger databases reported increased infection, thromboembolism, and systemic risks. Implant survival findings were mixed: Institutional cohorts showed no difference, whereas registry data indicated higher revision risk. Obese patients had lower baseline function but achieved comparable, meaningful improvements. Morbidly obese patients also improved without higher short-term complication rates. CONCLUSION Thus, obesity should not be a contraindication for TAA, though individualized counseling on risks and benefits is recommended.

Zitieren

APA

Pinto, I., Konstantinou, P., Kostretzis, L., Nikolaides, A. P., Ditsiou, A. Z., Chrysanthou, C., Kapetanakis, S., & Ditsios, K. (2026). Obesity and total ankle arthroplasty: Contraindication or consideration. World Journal of Orthopedics, 17(3). https://doi.org/10.5312/wjo.v17.i3.115288

Vancouver

Pinto I, Konstantinou P, Kostretzis L, Nikolaides AP, Ditsiou AZ, Chrysanthou C, et al. Obesity and total ankle arthroplasty: Contraindication or consideration. World Journal of Orthopedics. 2026;17(3). doi:10.5312/wjo.v17.i3.115288

BibTeX
@article{Pinto2026,
  author = {Pinto, Iosafat and Konstantinou, Panagiotis and Kostretzis, Lazaros and Nikolaides, Anastasios P and Ditsiou, Athina Zacharoula and Chrysanthou, Chrysanthos and Kapetanakis, Stylianos and Ditsios, Konstantinos},
  title = {Obesity and total ankle arthroplasty: Contraindication or consideration},
  journal = {World Journal of Orthopedics},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.5312/wjo.v17.i3.115288}
}
Kostenlos starten →